The nominations for this year's The Pathologist Power List are open.
12/05/2019 | Sponsored by Thermo Fisher Scientific
Whilst NGS has been instrumental to precision oncology research progress, practical hurdles have still been hindering its broad implementation…………Not anymore.
11/25/2019 | Sponsored by Royal College of Pathologists
To celebrate International Pathology Day 2019, we gathered a panel of experts to discuss the latest in point-of-care testing.
11/21/2019 | Sponsored by Philips
In this Webinar, Dr Juan Retamero, a Pathologist from Granada University Hospitals, Spain, will discuss the efficiency gains they have experienced since the implementation of a digital pathology workflow.
11/05/2019 | Sponsored by Illumina
Recent developments in cancer research, and rapidly increasing options for personalized therapeutics, showed the need for a comprehensive, fast and robust way to analyze the genetic information of DNA and RNA variants.
11/01/2019
Available On Demand
09/25/2019 | Sponsored by Pierian
Comprehensive genomic profiling assays provide extensive coverage of variants and immunotherapy biomarkers and increasingly enable physicians to provide cancer patients with more informed treatments.
09/07/2019 | Sponsored by Bristol-Myers Squibb
Pathologists play a crucial role in furthering advancements that may help predict which patients are likely to benefit from immuno-oncology therapies.
07/22/2019 | Sponsored by mTuitive
Is your lab ready for inspection? If not, how much time – and how much work – would it take to get there?
07/01/2019 | Sponsored by Philips
This webinar provides an overview of the key factors to consider when adopting a digital pathology solution and the benefits of digitization.
06/18/2019 | Sponsored by Ultivue
This webinar will focus on user experiences using the Ultivue InSituPlex fluorescence multiplex IHC platform.
05/14/2019 | Sponsored by Bristol-Myers Squibb
This webinar will review practical considerations for the preanalytical phase and explore the aspects that pathology may impact.
03/21/2019 | Sponsored by Thermo Fisher Scientific
With the emergence of a new class of targeted precision oncology therapies, NTRK fusions are increasingly becoming biomarkers that pathology laboratories can test for in FFPE tumor tissue.
Register to access our FREE online portfolio, request the magazine in print and manage your preferences.
Register
To Screen, or not to Screen?
Women in Pathology
The Matchmakers